Research In Brief
This article was originally published in The Gray Sheet
Executive Summary
NEJM publishes two trials of PFO closure for stroke prevention. First percutaneous heart pump implanted. Study finds cost savings with some minimally invasive procedures.
You may also be interested in...
RESPECT And PC Trial Results In, But Still No Real ‘Closure’ On PFO
There was some expectation leading up to TCT that the two trials could provide a definitive ruling on whether the PFO closure procedure had a future or not. But actual outcomes sparked a range of interpretations.
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.